Auxo Firm Directory · Independent Research Profile

Parthenon Capital Partners

Parthenon Capital Partners describes a management-oriented, research-driven private equity approach focused on niche sectors, complex situations, organic growth, acquisitions, and buy-and-build strategies.

Key takeaway

What stands out about Parthenon Capital Partners

Parthenon Capital Partners publicly identifies financial services, healthcare solutions, and business and technology services as its core sectors. Its official overview states $10B+ in capital commitments, a $100M-$1B transactional range, 60+ platform acquisitions, and 500+ add-on acquisitions. Its 2025 Year in Review states that Fund VII is a $4.6 billion pool of capital and that the firm is targeting $100 million to $500 million equity investments per platform, with the ability to reach $1 billion+ with LP co-investment.[1][2][4][5]

What does Parthenon Capital Partners invest in?

Parthenon Capital is a private equity firm that partners with and invests in management teams and their companies. It describes a collaborative model intended to support both acquisitive and organic growth, with relevant resources and insights for management teams.

The firm’s official overview states 40+ investment professionals, $10B+ in capital commitments, a $100M-$1B transactional range, 60+ platform acquisitions and 500+ add-on acquisitions. It also states that 70% of investments use buy-and-build strategies.[1]

Parthenon describes its approach as management-oriented, research-driven and thematic, with a focus on niche sectors, strategic and operational resources, and long-term value creation. The firm states that it works with management teams through both acquisitive and organic strategies.

Its publicly described resources include strategy and operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A. These capabilities are presented as resources and insights available to support portfolio companies.[1][2]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Published size criteriaPublicly stated range
Lower published point$10
Upper published point$1BILLION+

Published criteria: The official overview states 40+ investment professionals, $10B+ in capital commitments, a $100M-$1B transactional range, 60+ platform acquisitions, 500+ add-on acquisitions, and 70% of investments using buy-and-build strategies. The 2025 Year in Review states that Fund VII is a $4.6 billion pool of capital and that the firm is targeting $100 million to $500 million equity investments per platform, with the ability to reach $1 billion+ with LP co-investment.[1][4]

What should a business owner evaluate before considering a transaction with Parthenon Capital Partners?

An owner evaluating a sale or recapitalization should clarify how Parthenon’s stated management partnership, platform investment model and buy-and-build activity would apply to the specific company. Discussion points include ownership structure, rollover equity, control and board representation, management continuity, expected acquisition activity, leverage, fund or vehicle horizon, and the operating, technology, M&A, talent and finance resources assigned to the company.

Parthenon’s public materials describe substantial capital commitments and platform and add-on activity, but the materials described here do not establish the terms that would apply to a particular transaction.[1][4][5]

01

What ownership structure and rollover-equity expectations would apply to a new platform investment

Parthenon publicly describes platform investments and management partnerships, while the materials described here do not establish the ownership terms for a particular transaction.[1][5]
02

What level of control and board representation would Parthenon seek

The firm describes collaborative work with management teams, but the materials described here do not specify control or governance terms for a prospective investment.[1][2][5]
03

Which operating, technology, M&A, talent and finance resources would be dedicated to the company

Parthenon identifies strategy and operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A among its resources; the specific allocation to a company is not stated.[1][2]

What companies does Parthenon Capital Partners target?

Parthenon publicly describes a focus on niche sectors, dynamic niches, consolidation opportunities, corporate carve-outs, and other complicated situations. Its stated transaction range is $100M-$1B.

The 2025 Year in Review states that Fund VII is a $4.6 billion pool of capital and that Parthenon is targeting $100 million to $500 million equity investments per platform, with the ability to reach $1 billion+ with LP co-investment. The official overview does not identify the specific fund or vehicle applicable to a prospective new platform investment.[1][2][4]

Parthenon’s three stated core sectors are financial services, healthcare solutions, and business and technology services.

Publicly stated financial-services areas include financial software and analytics, integrated payments and payment processing, insurance services, brokers and exchanges, wealth and asset management, capital-markets software, specialty lending, collections and employee benefits. Healthcare-solutions areas include HCIT, revenue-cycle management, practice management and technology, healthcare payments, life-sciences technology and outsourcing, pharmacy services, benefits administration and health insurance. Business and technology services areas include human capital management, business process outsourcing, SaaS and niche software, professional services, legal, regulatory and compliance services, IT and managed services, and data-center services.[3]

Parthenon lists three strategic offices across the United States: Boston, San Francisco and Austin. Public transaction announcements also describe portfolio-company activity involving the United States and, for DaySmart’s announced acquisition of UK salon platform Slick, the United Kingdom.

The materials described here do not establish a single exclusive geographic investment mandate.[1][8]

Parthenon publicly reports both platform investments and add-on acquisitions. Its official overview states 60+ platform acquisitions and 500+ add-on acquisitions, with 70% of investments using buy-and-build strategies.

The firm also states that approximately two-thirds of its portfolio is highly acquisitive, averaging eight add-ons per company. Its 2025 Year in Review identifies four new platform investments and 31 add-on acquisitions at 11 portfolio companies.[1][4]

Parthenon’s representative-investments page identifies active portfolio companies including AArete, BirchStreet, CardWorks, Cherry Bekaert, Choreo, DaySmart, EdgeCo Holdings, Embark, KBRA, MRO, Payroc, Titan Wealth, Venbrook and Zelis.

The page lists portfolio-company names and active or exited status, but does not disclose acquisition dates, transaction values, purchase-price allocations, financing terms or consideration terms for each listed investment.[5]

Recent official announcements include Momentum Life Sciences’ announcement on July 1, 2026 of a strategic investment from Parthenon Capital. The announcement states that existing leadership would continue as significant shareholders and that the investment would support growth and strategic acquisitions.

On May 11, 2026, Ascensus announced a definitive agreement to acquire AmericanTCS; the announcement described the transaction as expected to close in Q3 2026 subject to customary conditions. On March 31, 2026, DaySmart announced its acquisition of UK salon platform Slick.

Parthenon’s 2025 Year in Review identifies the recapitalization of MRO and acquisition of Q-Centrix, recapitalization of AArete, acquisition of Elevate, partnership with Embark, and a continuation vehicle and new investment in KBRA as new platform investments or major investment events. It also reports seven total liquidity events since January 1, 2025 totaling $2.2 billion in distributions.[4][6][7][8]

What is not clear from Parthenon Capital Partners's public investment criteria?

The representative-investments page does not disclose acquisition dates, transaction values, purchase-price allocations, financing terms or consideration terms for each listed investment.

The 2025 Year in Review describes long-term investment thinking and value creation but does not specify a universal numeric ownership duration, investment horizon or exit timetable. The official overview also does not identify the specific fund or vehicle applicable to a prospective new platform investment.[1][4][5]

Questions to ask when evaluating Parthenon Capital Partners as a buyer or investment partner

What ownership structure and rollover-equity expectations would apply to a new platform investment?
Parthenon publicly describes platform investments and management partnerships, while the materials described here do not establish the ownership terms for a particular transaction.[1][5]
What level of control and board representation would Parthenon seek?
The firm describes collaborative work with management teams, but the materials described here do not specify control or governance terms for a prospective investment.[1][2][5]
Which operating, technology, M&A, talent and finance resources would be dedicated to the company?
Parthenon identifies strategy and operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A among its resources; the specific allocation to a company is not stated.[1][2]
Would the company be expected to pursue a buy-and-build strategy, and what acquisition pace or leverage parameters would apply?
Parthenon reports substantial platform and add-on activity and states that 70% of investments use buy-and-build strategies, but the materials described here do not establish the acquisition pace or leverage parameters for a specific company.[1][4][5]
What is the expected investment horizon and exit approach for the specific fund or vehicle?
The 2025 Year in Review does not specify a universal numeric ownership duration, investment horizon or exit timetable, and the official overview does not identify the fund or vehicle applicable to a prospective new platform investment.[1][4]
How does Parthenon handle management succession, founder roles and retained ownership?
A recent Momentum Life Sciences announcement states that existing leadership would continue as significant shareholders, but the materials described here do not establish that this structure applies to every investment.[6]
What fund-level fees, expenses, debt policies and co-investment arrangements would apply?
The 2025 Year in Review states that platform equity investments may reach $1 billion+ with LP co-investment, while the materials described here do not establish deal-specific fees, expenses or debt policies.[4][5]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Investment approach
  3. Industry / market focus
  4. Transaction size / criteria
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. SEC filing / regulatory record
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.